Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Biotechs Seek To Outsource Drug Marketing To MNCs

This article was originally published in PharmAsia News

Executive Summary

In somewhat of a trend reversal, some Indian biotechs are outsourcing their own drug projects as the drug-making business tightens. Avesthagen and Biocon have their own pipeline of drugs in development, but are discussing possible partnerships with multinational drug makers. Avesthagen has a nutritional molecule in clinical trials and seeks a MNC willing to market the drug while Avesthagen focuses on four other molecules in the pre-clinical stage. Biocon is in a similar situation with an insulin molecule just entering Phase III trials. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071261

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel